PARP Inhibition in Recurrent Prostate Cancer

home / expertconnections / parp-inhibition-in-recurrent-prostate-cancer
Diagnosis of Prostate Cancer

EP. 1: Diagnosis of Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Genetic Counseling for Prostate Cancer

EP. 2: Genetic Counseling for Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Impact of BRCA Mutations in Prostate Cancer

EP. 3: Impact of BRCA Mutations in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

FDA-Approved PARP Inhibitors for Prostate Cancer

EP. 4: FDA-Approved PARP Inhibitors for Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Quality of Life With Prostate Cancer

EP. 5: Quality of Life With Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Patient’s Role in Decision-Making for Prostate Cancer

EP. 6: Patient’s Role in Decision-Making for Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

The Future of PARP Inhibitors in Prostate Cancer

EP. 7: The Future of PARP Inhibitors in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Metastatic Castration-Resistant Prostate Cancer Overview

EP. 8: Metastatic Castration-Resistant Prostate Cancer Overview

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Receiving a Prostate Cancer Diagnosis

EP. 9: Receiving a Prostate Cancer Diagnosis

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Prostate Cancer: Learning About Treatment Options

EP. 10: Prostate Cancer: Learning About Treatment Options

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Testing for Mutations in Prostate Cancer

EP. 11: Testing for Mutations in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Talking About Gene Testing in Prostate Cancer

EP. 12: Talking About Gene Testing in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

John Litten: Participating on a PARP Clinical Trial for mCRPC

EP. 13: John Litten: Participating on a PARP Clinical Trial for mCRPC

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Treatment Options Available for mCRPC

EP. 14: Treatment Options Available for mCRPC

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

PARP Inhibitors in Recurrent mCRPC

EP. 15: PARP Inhibitors in Recurrent mCRPC

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Advice to Patients Facing mCRPC

EP. 16: Advice to Patients Facing mCRPC

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Future Use of PARP Inhibition in Prostate Cancer

EP. 17: Future Use of PARP Inhibition in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch

Advances in Prostate Cancer

EP. 18: Advances in Prostate Cancer

Alan H. Bryce, MD, Mayo Clinic;John Litten, Patient & Advocate
September 28th 2020

Watch